IRT Independence posts 458 percent Q4 2025 earnings beat alongside 28 percent year over year revenue growth CURX Curanex CEO highlights upcoming specialty drug launches as core growth driver for coming fiscal year Prediction Market Geopolitical Trading Risks and Regulatory Outlook Orrstown ORRF Stock Sector Leadership Volatility Increases 20260420 JDcom Inc JD PostRally Underperformance Upcoming Earnings Catalyst and Valuation Outlook